Table: Pharmarise Holdings - 9-MTH group results

Pharmarise Holdings

30/03/2023 09:00

Mar 30 (Reuters)- 
             Pharmarise Holdings Corp 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Feb 28, 2023        Feb 28, 2022     May 31, 2023 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               38.73               38.58            51.79    
                   (+0.4 pct)          (+0.3 pct)       (+0.4 pct)  
  Operating          896 mln               1.00             1.41    
                   (-10.4 pct)         (+31.4 pct)      (-7.2 pct)  
  Recurring          890 mln               1.01             1.38    
                   (-12.2 pct)         (+65.7 pct)      (-9.1 pct)  
  Net                208 mln             322 mln          397 mln   
                   (-35.2 pct)        (+182.5 pct)      (-11.3 pct) 
  EPS               22.24 yen           34.60 yen        42.27 yen  
  EPS Diluted       16.89 yen           26.16 yen                   
  Ann Div                               14.00 yen        14.00 yen  
  -Q2 div              NIL                 NIL                      
  -Q4 div                               14.00 yen        14.00 yen  
  
  NOTE - Pharmarise Holdings Corp. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2796.T